Comment
. 2010 Oct 5;122(14):e478; author reply e479.
doi: 10.1161/CIRCULATIONAHA.110.943548.
Letter by Gurbel et al regarding article, "Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement"
- PMID: 20921447
- DOI: 10.1161/CIRCULATIONAHA.110.943548
Item in Clipboard
Comment
Letter by Gurbel et al regarding article, "Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement"
Circulation.
.
No abstract available
Comment on
-
Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.Circulation. 2010 Feb 2;121(4):512-8. doi: 10.1161/CIRCULATIONAHA.109.885194. Epub 2010 Jan 18. Circulation. 2010. PMID: 20083681
Similar articles
-
Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.Circulation. 2010 Feb 2;121(4):512-8. doi: 10.1161/CIRCULATIONAHA.109.885194. Epub 2010 Jan 18. Circulation. 2010. PMID: 20083681
-
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study.Lancet. 2009 Jan 24;373(9660):309-17. doi: 10.1016/S0140-6736(08)61845-0. Epub 2008 Dec 26. Lancet. 2009. PMID: 19108880 Clinical Trial.
-
Cytochrome p-450 polymorphisms and response to clopidogrel.N Engl J Med. 2009 Jan 22;360(4):354-62. doi: 10.1056/NEJMoa0809171. Epub 2008 Dec 22. N Engl J Med. 2009. PMID: 19106084
-
Proton pump inhibitors and clopidogrel.Cardiovasc Ther. 2010 Jun;28(3):169-76. doi: 10.1111/j.1755-5922.2010.00143.x. Epub 2010 Mar 25. Cardiovasc Ther. 2010. PMID: 20345494 Review.
-
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.Expert Opin Drug Metab Toxicol. 2010 Apr;6(4):393-407. doi: 10.1517/17425251003598878. Expert Opin Drug Metab Toxicol. 2010. PMID: 20163283 Review.
Cited by
-
The clinical relevance of the clopidogrel-proton pump inhibitor interaction.J Cardiovasc Transl Res. 2012 Aug;5(4):547-52. doi: 10.1007/s12265-011-9334-7. Epub 2012 Feb 14. J Cardiovasc Transl Res. 2012. PMID: 22351048 Review.
-
Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial.Trials. 2017 Nov 9;18(1):529. doi: 10.1186/s13063-017-2277-9. Trials. 2017. PMID: 29121979 Free PMC article. Clinical Trial.
-
Cardiovascular pharmacogenomics.Circ Res. 2011 Sep 16;109(7):807-20. doi: 10.1161/CIRCRESAHA.110.230995. Circ Res. 2011. PMID: 21921273 Free PMC article. Review.
-
Pharmacogenomics: application to the management of cardiovascular disease.Clin Pharmacol Ther. 2011 Oct;90(4):519-31. doi: 10.1038/clpt.2011.179. Epub 2011 Sep 14. Clin Pharmacol Ther. 2011. PMID: 21918509 Free PMC article.
-
Pharmacogenomics of anti-platelet and anti-coagulation therapy.Curr Cardiol Rep. 2013 Jul;15(7):381. doi: 10.1007/s11886-013-0381-3. Curr Cardiol Rep. 2013. PMID: 23797323 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
